- Home
- DNLI vs APPN Comparison
DNLI vs APPN Comparison
Compare DNLI & APPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- APPN
- Stock Information
- Founded
- DNLI 2013
- APPN 1999
- Country
- DNLI United States
- APPN United States
- Employees
- DNLI N/A
- APPN N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- APPN Computer Software: Prepackaged Software
- Sector
- DNLI Health Care
- APPN Technology
- Exchange
- DNLI Nasdaq
- APPN Nasdaq
- Market Cap
- DNLI 2.2B
- APPN 2.0B
- IPO Year
- DNLI 2017
- APPN 2017
- Fundamental
- Price
- DNLI $14.93
- APPN $28.89
- Analyst Decision
- DNLI Strong Buy
- APPN Hold
- Analyst Count
- DNLI 13
- APPN 6
- Target Price
- DNLI $32.64
- APPN $34.40
- AVG Volume (30 Days)
- DNLI 1.5M
- APPN 620.7K
- Earning Date
- DNLI 11-03-2025
- APPN 11-06-2025
- Dividend Yield
- DNLI N/A
- APPN N/A
- EPS Growth
- DNLI N/A
- APPN N/A
- EPS
- DNLI N/A
- APPN N/A
- Revenue
- DNLI N/A
- APPN $657,803,000.00
- Revenue This Year
- DNLI N/A
- APPN $15.42
- Revenue Next Year
- DNLI $94,232.03
- APPN $11.07
- P/E Ratio
- DNLI N/A
- APPN N/A
- Revenue Growth
- DNLI N/A
- APPN 13.67
- 52 Week Low
- DNLI $10.57
- APPN $24.00
- 52 Week High
- DNLI $33.33
- APPN $43.33
- Technical
- Relative Strength Index (RSI)
- DNLI 42.86
- APPN 42.11
- Support Level
- DNLI $15.53
- APPN $29.38
- Resistance Level
- DNLI $17.02
- APPN $30.63
- Average True Range (ATR)
- DNLI 0.79
- APPN 0.91
- MACD
- DNLI -0.19
- APPN 0.00
- Stochastic Oscillator
- DNLI 0.71
- APPN 34.62
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About APPN Appian Corporation
Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.